HSBC will sell its life and health insurance business in Singapore to Allianz for S$2.7 billion, equivalent to about $2.1 billion, the bank said, as it pares back non-core operations and concentrates on its Asian wealth and wholesale banking activities.
Under the terms of the agreement, HSBC will transition to a capital-light bancassurance model in Singapore. That shift allows the bank to derive fee-based revenue from distributing insurance products without the need to hold capital reserves or maintain underwriting books for the business - a move consistent with HSBC’s stated ambition to evolve into a leaner wealth manager over time.
The disposal is expected to generate a pre-tax gain of $1.8 billion for HSBC and to lift its common equity tier 1, or CET1, capital ratio by as much as 15 basis points. In morning trading the bank’s Hong Kong-listed shares were down 1.1%, roughly in line with broader market moves.
Allianz, by acquiring HSBC’s Singapore life and health unit, secures further presence in one of Asia’s major wealth hubs and gains access to affluent customers through bank distribution arrangements. The transaction also represents a renewed push by Allianz in Singapore after it had previously withdrawn a 2024 offer to buy at least 51% of Income Insurance - formerly NTUC Income - following public concern and government intervention.
HSBC will continue to sell Allianz insurance products in Singapore for a minimum of 15 years as part of the agreement. That ongoing distribution arrangement is supported by an upfront payment of S$200 million. Insurers prize such arrangements because they provide access to large numbers of affluent clients in Singapore, a key market in the region for wealth management and insurance distribution.
Analysts noted the capital benefit from the sale could give HSBC greater flexibility over capital allocation. Ralph Chen, a senior research analyst at S&P Global Market Intelligence, said the move is expected to strengthen HSBC’s capital position via a higher CET1 ratio. Chen added that the extra capital could allow the bank to resume share buybacks, pay a special dividend or reallocate funds to faster-growing areas such as private credit, although HSBC has not disclosed specific plans for the sale proceeds.
The transaction is scheduled to be finalised in the first half of 2027. As part of HSBC’s ongoing portfolio adjustments, the bank previously purchased AXA’s Singapore business for $529 million in 2022 and in May said it was reviewing HSBC Life Singapore’s insurance "manufacturing" operations.
HSBC’s divestment in Singapore forms part of a broader effort led by CEO Georges Elhedery to simplify the operations of Europe’s largest bank and redeploy capital into businesses and markets expected to offer stronger returns, while retaining Singapore as a key hub for wealth and wholesale banking.
Allianz described the deal as an affirmation of its long-term commitment to Singapore. Anusha Thavarajah, Regional CEO of Allianz Asia Pacific, said the transaction reinforces the firm’s confidence in the market and cited HSBC Life Singapore’s rapid growth and local expertise as underpinning the business’s customer and partner trust.
The move is consistent with a trend among global banks to slim down smaller or less-scalable retail and insurance operations across parts of Asia even as they compete for affluent clients. For example, in May Oversea-Chinese Banking Corp said its Indonesian unit would acquire certain assets and liabilities from HSBC’s wealth and premier banking portfolio in Indonesia. HSBC has also indicated it is reviewing its retail businesses in Turkey, Australia and Egypt.
The sale is likely to be watched by market participants for its capital and strategic consequences for HSBC, and for how Allianz leverages the acquired business and the long-term distribution agreement to grow in Singapore’s competitive insurance market. ($1 = 1.2923 Singapore dollars)